check_circleStudy Completed
Bayer Identifier:
17861
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
EU CT Number:
Not Available
Relative bioavailability of rivaroxaban under different administration conditions
Trial purpose
Key Participants Requirements
Sex
MaleAge
18 - 55 YearsTrial summary
Enrollment Goal
16Trial Dates
March 2015 - June 2015Phase
Phase 1Could I Receive a placebo
N/AProducts
Xarelto (Rivaroxaban, BAY59-7939)Accepts Healthy Volunteer
YesWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Mannheim, 68167, Germany |
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
RandomizedBlinding
Open LabelAssignment
Crossover AssignmentTrial Arms
N/A